Topiramate Versus Naltrexone for Alcohol Use Disorder: A Genotype-Stratified Double-Blind Randomized Controlled Trial (vol 181, pg 403, 2024)

被引：0
|
作者：
Morley, Kirsten C.
机构：
来源：
AMERICAN JOURNAL OF PSYCHIATRY | 2024年 / 181卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：775 / 775
页数：1
相关论文
共 50 条
  • [1] Topiramate Versus Naltrexone for Alcohol Use Disorder: A Genotype-Stratified Double-Blind Randomized Controlled Trial
    Morley, Kirsten C.
    Kranzler, Henry R.
    Luquin, Natasha
    Jamshidi, Nazila
    Adams, Claire
    Montebello, Mark
    Tremonti, Chris
    Dali, Gezelle
    Logge, Warren
    Baillie, Andrew
    Teesson, Maree
    Trent, Ronald
    Haber, Paul S.
    AMERICAN JOURNAL OF PSYCHIATRY, 2024, 181 (05): : 403 - 411
  • [2] Topiramate versus naltrexone for alcohol use disorder: study protocol for a genotype-stratified, double-blind randomised controlled trial (TOP study)
    Kirsten C. Morley
    Henry R. Kranzler
    Natasha Luquin
    Andrew Baillie
    Marian Shanahan
    Ronald Trent
    Maree Teesson
    Paul S. Haber
    Trials, 19
  • [3] Topiramate versus naltrexone for alcohol use disorder: study protocol for a genotype-stratified, double-blind randomised controlled trial (TOP study)
    Morley, Kirsten C.
    Kranzler, Henry R.
    Luquin, Natasha
    Baillie, Andrew
    Shanahan, Marian
    Trent, Ronald
    Teesson, Maree
    Haber, Paul S.
    TRIALS, 2018, 19
  • [4] A Randomized, Double-Blind, Placebo-Controlled Trial of Naltrexone in the Treatment of Concurrent Alcohol Use Disorder and Pathological Gambling
    Toneatto, Tony
    Brands, Bruna
    Selby, Peter
    AMERICAN JOURNAL ON ADDICTIONS, 2009, 18 (03): : 219 - 225
  • [5] Double-Blind Randomized Clinical Trial of Prazosin for Alcohol Use Disorder
    Simpson, Tracy L.
    Saxon, Andrew J.
    Stappenbeck, Cynthia
    Malte, Carol A.
    Lyons, Robert
    Tell, Dana
    Millard, Steven P.
    Raskind, Murray
    AMERICAN JOURNAL OF PSYCHIATRY, 2018, 175 (12): : 1216 - 1224
  • [6] A Randomized, Double-Blind, Placebo-Controlled Trial of Citicoline in Patients with Alcohol Use Disorder
    Brown, E. Sherwood
    Van Enkevort, Erin
    Kulikova, Alexandra
    Escalante, Chastity
    Nakamura, Alyson
    Ivleva, Elena I.
    Holmes, Traci
    ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2019, 43 (02): : 317 - 323
  • [7] N acetylcysteine in the treatment of alcohol use disorder: a randomized, double-blind, placebo-controlled trial
    Morley, Kirsten C.
    Peruch, Siena
    Adams, Claire
    Towers, Ellen
    Tremonti, Chris
    Watt, Joshua
    Jamshidi, Nazila
    Haber, Paul S.
    ALCOHOL AND ALCOHOLISM, 2023, 58 (05): : 553 - 560
  • [8] Naltrexone versus acamprosate in the treatment of alcohol dependence: a multi-centre, randomized, double-blind, placebo-controlled trial
    Morley, Kirsten C.
    Teesson, Maree
    Reid, Sophie C.
    Sannibale, Claudia
    Thomson, Clare
    Phung, Nghi
    Weltman, Martin
    Bell, James R.
    Richardson, Kylie
    Haber, Paul S.
    ADDICTION, 2006, 101 (10) : 1451 - 1462
  • [9] Low-dose topiramate in alcohol dependence: a randomized, double-blind, placebo-controlled trial
    Hatzigiakoumis, D. S.
    Martinotti, G.
    De Vita, O.
    Di Nicola, M.
    Gualtieri, I.
    Tedeschi, D.
    Guglielmo, R.
    Quatrale, M.
    Pozzi, G.
    Janiri, L.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S391 - S391
  • [10] LOW-DOSAGE TOPIRAMATE IN ALCOHOL DEPENDENCE: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    Martinotti, G.
    Di Nicola, M.
    De Vita, O.
    Tedeschi, D.
    Guerriero, L.
    Guglielmo, R.
    De Filippis, R.
    Janiri, L.
    EUROPEAN PSYCHIATRY, 2010, 25
12345